Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
Objectives We identified factors associated with thromboembolic and bleeding events in two contemporary cohorts of anticoagulated patients with atrial fibrillation (AF), treated with either vitamin K antagonists (VKA) or non-VKA oral anticoagulants (NOACs).Design Prospective, multicentre observation...
Saved in:
Main Authors: | Raffaele De Caterina, Kurt Huber, Richard Schilling, Miklos Rohla, Thomas W Weiss, Ladislav Pecen, Giuseppe Patti, Jolanta M Siller-Matula, Renate B Schnabel, Dipak Kotecha, Markus Lucerna, Paulus Kirchhof |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-03-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/9/3/e022478.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recurrence of atrial fibrillation and late cardiovascular events in patients with persistent atrial fibrillation after restoration of sinus rhythm
by: U.P. Chernyaha-Royko, et al.
Published: (2020-06-01) -
Pre-existing atrial fibrillation and risk of arterial thromboembolism and death following pneumonia: a population-based cohort study
by: Reimar Wernich Thomsen, et al.
Published: (2014-11-01) -
Change in Atrial Fibrillation Burden over Time in Patients with Nonpermanent Atrial Fibrillation
by: Philipp Krisai, et al.
Published: (2020-01-01) -
The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry
by: Rungroj Krittayaphong, et al.
Published: (2022-01-01) -
Atrial Fibrillation: Mechanisms and Management
by: Tong Liu, et al.
Published: (2019-01-01)